Standard Drug Discovery and Development

$1 to $2 billion

Cost of a new drug development

10 to 15 years

To develop a new drug

1:10k

Success rate

We can reduce those numbers to

$250k – $50M

Cost of a new drug development

4 to 5 years

To develop a new drug

3:10

Success rate

OUR APPROACH

Artificial Intelligence

Propietary Databases of Chemical Structures

Scientific Expertise

Our Directions of Work

Proprietary pipeline

Proprietary pipeline

PARTNERSHIP

Our performance indicators

12%

of our performed projects have
reached Clinical Phase 2

29%

of our projects have a positive
in vitro lead

We cooperate with

SOM Biotech in the media

LATEST NEWS

HAPPY END OF THE 2020!
December 21, 2020

We wish a happy and healthy holiday to everyone who has trusted SOM Biotech during this challenging year marked by the Covid-19 pandemic. Thank you, especially to the entire team, whose hard work has been essential in such a demanding year. We wish you a safe and Merry Christmas and ...

SOM Biotech ends a notable year 2020
SOM Biotech ends 2020 with an advanced and robust pipeline that strengthens the company’s future
December 21, 2020

SOM Biotech ends the notable year 2020 with relevant advances in its pipeline. The company started 2020 with positive results from the Phase 2a proof-of-concept to evaluate the safety and efficacy of SOM3355, an inhibitor of the Vesicular Monoamine Transporter-2 (VMAT2), in Huntington´s disease (HD) patients with chorea. The clinical ...

SOM Biotech at the BIO- Partnering JPM Virtual Event 2021
December 18, 2020

SOM Biotech announces its participation at the BIO-Partnering at JP Morgan Healthcare Conference 2021, being held virtually on January 11th – 15th. The conference, a leading virtual partnering and business development initiative for the biotechnology industry organized by Biotechnology Innovation Organization, provides a One-on-One partnering platform to give companies access ...

A pioneering real AI drug discovery technology
European Biotechnology: “A pioneering real AI drug discovery technology”
November 26, 2020

European Biotechnology Life Science and Industry Magazine published the article “A pioneering real AI drug discovery technology” describing the approach of SOM Biotech. The current COVID-19 pandemic situation has shown that repurposing drugs can be crucial for delivering new treatments to patients with agility. Existing drugs can be developed to ...

La Vanguardia press release: “The future of biotechnology: lower-cost treatments in a short period of time”
November 26, 2020

La Vanguardia published a press release: “The future of biotechnology: lower-cost treatments in a short period of time”. You can find a short overview of the press release below. SOM Biotech has designed a computational Artificial Intelligence-based method to analyze molecular structures and select the best option after performing more ...

SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech keynote speaker at the Drug Discovery Innovation Programme Virtual Event 2020
November 16, 2020

SOM Biotech announces its participation at the Drug Discovery Innovation Programme event 2020, being held virtually on November 17th. The conference will be chaired by Kevin McAllister, PhD, MBA Chief Scientific Officer. As a keynote speaker, Maria Zimina, PhD. MBA, Business Development Manager, will present “AI Evolutionary Algorithms for the ...

SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech presents its drug candidate for the Chorea in Huntington Disease at the XIX Pharma – Biotech Cooperation conference
November 10, 2020

SOM Biotech presents its drug candidate SOM3355 for the Chorea in Huntington Disease at the XIX Pharma-Biotech Cooperation conference, November 12th 2020. The conference, an initiative of Farmaindustria – the National Trade Association of the Spanish based pharmaceutical industry –  allows companies previously selected for their contribution to innovation, to present ...

SOM Biotech ends 2020 with an advanced and robust pipeline
SOM Biotech at BIO-Europe 2020 Digital Convention
October 20, 2020

SOM Biotech will attend the “BIO-Europe 2020” convention on October 26th – 29th, which will take place digitally due to the pandemic situation. Raúl Insa, CEO of SOM Biotech: “BIO-Europe 2020 is one of the most relevant partnering events for the life science sector. We look forward to meeting with ...